This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (25) Citing Articles via Google Scholar Google Scholar Articles by Glezer, I. Articles by Rivest, S. Search for Related Content PubMed PubMed Citation Articles by Glezer, I. Articles by Rivest, S. Social Bookmarking                   What's this?

Glucocorticoids: Protectors of the Brain during Innate Immune Responses

Laboratory of Molecular Endocrinology, CHUL Research Center, Department of Anatomy and Physiology, Laval University

Serge Rivest

Laboratory of Molecular Endocrinology, CHUL Research Center, Department of Anatomy and Physiology, Laval University, serge.rivest{at}crchul.ulaval.ca

The innate immune response is a coordinated set of reactions involving cells of myeloid lineage and a network of signaling molecules. Such a response takes place in the CNS during trauma, stroke, spinal cord injury, and neurodegenerative diseases, suggesting that macrophages/microglia are the cells that perpetuate the progressive neuronal damage. However, there is accumulating evidence that these cells and their secreted proinflammatory molecules have more beneficial effects than detrimental consequences for the neuronal elements. Indeed, a timely controlled innate immune response may limit toxicity in swiftly eliminating foreign materials and debris that are known to interfere with recovery and regeneration. Each step of the immune cascade is under the tight control of stimulatory and inhibitory signals. Glucocorticoids (GCs) act as the critical negative feedback on all myeloid cells, including those present within the brain parenchyma. Because too little is like too much, both an inappropriate feedback of GCs on microglia and high circulating GC levels in stressed individuals have been associated with deleterious consequences for the brain. In this review, the authors discuss both sides of the story with a particular emphasis on the neuro-protective role of endogenous GCs during immune challenges and the problems in determining whether GCs can be a good therapy for the treatment of neuropathological conditions.

Key Words: Innate immune response • Inflammation • Glucocorticoids • Proinflammatory cytokines • Microglia • Neurodegeneration • Neuroprotection

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. Boivin, I. Pineau, B. Barrette, M. Filali, N. Vallieres, S. Rivest, and S. Lacroix Toll-Like Receptor Signaling Is Critical for Wallerian Degeneration and Functional Recovery after Peripheral Nerve Injury J. Neurosci., November 14, 2007; 27(46): 12565 - 12576. [Abstract] [Full Text] [PDF]

				T. M. Coyne, A. J. Marcus, D. Woodbury, and I. B. Black Marrow Stromal Cells Transplanted to the Adult Brain Are Rejected by an Inflammatory Response and Transfer Donor Labels to Host Neurons and Glia Stem Cells, November 1, 2006; 24(11): 2483 - 2492. [Abstract] [Full Text] [PDF]

				B. D. Hoehn, T. D. Palmer, and G. K. Steinberg Neurogenesis in Rats After Focal Cerebral Ischemia is Enhanced by Indomethacin Stroke, December 1, 2005; 36(12): 2718 - 2724. [Abstract] [Full Text] [PDF]